87.75SEK-2.12%Mkt Cap: 1.14B $P/E: —1d ago
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse…
Indicators:|
Key Statistics
Company
Market Cap1.14B $
Enterprise Value1.20B $
Revenue (TTM)325.70M $
Gross Profit191.02M $
Net Income (TTM)-479.41M $
Revenue/Share2.405 USD
Last Price87.75 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.1K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011205202
Valuation
P/E (Trailing)—
P/E (Forward)18.24
PEG2.02
EV/EBITDA13.44
EV/Revenue3.69
P/S3.49
P/B1.47
EPS (TTM)-37.01
EPS (Forward)4.81
52W Range
84.605% of range153.50
52W High153.50 SEK
52W Low84.60 SEK
Profitability
Gross Margin58.05%
Oper. Margin18.46%
EBITDA Margin27.49%
Profit Margin-145.70%
ROE-63.49%
ROA-45.06%
Growth
Revenue Growth-4.20%
Earnings Growth0.20%
Cash Flow & Leverage
Operating CF60.74M $
CapEx (TTM)23.63M $
FCF Margin15.50%
FCF Yield4.44%
Net Debt66.57M $
Net Debt/EBITDA0.74
Balance Sheet
Debt/Equity0.20
Current Ratio3.68
Quick Ratio2.83
Book Value/Sh59.58 SEK
Cash/Share6.542 SEK
Dividends
Fwd Div Rate1.100 SEK
Trail. Div Rate1.100 SEK
Div. Yield1.24%
5Y Avg Yield0.50%
Payout Ratio33.85%
Ex-Div DateMay 6, 2026
Pay Date—
Splits
Last Split5:1
Split DateMay 17, 2018
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)149.20 SEK
Upside (mean)+70.0%
Target Range95.00 SEK – 215.00 SEK
SEK95.00+70.0% to meanSEK215.00
# Analysts5
Ownership
Shares Out.135.45M
Float73.71M
Insiders29.72%
Institutions62.11%
Technical
SMA 50101.30 (-13.4%)
SMA 200116.18 (-24.5%)
Beta1.70
S&P 52W Chg20.05%
Avg Vol (30d)311.88K
Avg Vol (10d)219.72K
Technical Indicators
RSI (14)31.3
MACD-3.5924
MACD Signal-3.2818
MACD Hist.-0.3106
BB Upper100.70 SEK
BB Middle93.29 SEK
BB Lower85.88 SEK
BB Width15.88%
ATR (14)3.121 SEK
Vol Ratio (20d)0.48x